Cardiovascular Outcomes in Hypertension-Treated Patients With Peripheral Artery Disease: The VALUE Trial
Sign Up to like & getrecommendations! Published in 2024 at "Hypertension"
DOI: 10.1161/hypertensionaha.124.22832
Abstract: BACKGROUND: Systolic blood pressure (BP) is a key predictor of cardiovascular events, but patients with peripheral artery disease (PAD) are rarely included in hypertension trials. The VALUE trial (Valsartan Antihypertensive Long-Term Use Evaluation) investigated the… read more here.
Keywords: patients peripheral; peripheral artery; value trial; cardiovascular outcomes ... See more keywords